BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Amniocentesis
,
Quercetin
,
rs2230926
,
PBX1
,
Apoptosis
,
Diabetes mellitus
,
Embryo
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dystroglycan
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Olfactory bulb
Placenta
Trigeminal ganglia
Dorsal root ganglia
Skeletal muscle
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Muscular dystrophy
Periodontitis
11p partial monosomy syndrome
Pneumonia
Vesicular stomatitis Indiana virus disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
N-acetyl-1-aspartylglutamic acid
benz(a)anthracene
Iohexol
Dapsone
Trimeprazine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR142
RICTOR
C9orf72
PRKG1
MIR142
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene.
Deletion of POMT2 in Zebrafish Causes Degeneration of Photoreceptors.
DAG1 haploinsufficiency is associated with sporadic and familial isolated or pauci-symptomatic hyper…
Conditional Inactivation of Nf1 and Pten in Schwann Cells Results in Abnormal Neuromuscular Junction…
A novel 1-bp deletion variant in DAG1 in Japanese familial asymptomatic hyper-CK-emia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Trial Readiness for the Dystroglycanopathies
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
Open Label Phase 2 Study of BBP-418 in Patients With LGMD2I
Biomarker Development in LGMD2i
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ